Frederick Sullivan Biography and Net Worth

CFO of Senseonics


Rick Sullivan is the Chief Financial Officer at Senseonics, Inc.

Rick is responsible for all aspects of finance and accounting. Rick first joined Senseonics in 2011 and has served as the Vice President of Finance, Treasurer, Head of Strategy and Financial Reporting and Corporate Controller.

Prior to rejoining Senseonics in 2020, Rick served as Chief Financial Officer for RoosterBio, Inc., a privately held regenerative medicine company and as the Principal of Hike Financial, LLC, an advisory firm that provides financial, accounting and administrative services to early growth, life sciences and technology companies.

Rick received his M.B.A. from the University of Maryland, Robert H. Smith School of Business, his B.S. in accounting from Salisbury University, Perdue School of Business. Rick maintains an active CPA license in the state of Maryland.

What is Frederick T. Sullivan's net worth?

The estimated net worth of Frederick T. Sullivan is at least $1.06 million as of November 7th, 2025. Mr. Sullivan owns 157,028 shares of Senseonics stock worth more than $1,056,798 as of December 4th. This net worth approximation does not reflect any other assets that Mr. Sullivan may own. Learn More about Frederick T. Sullivan's net worth.

How old is Frederick T. Sullivan?

Mr. Sullivan is currently 42 years old. There are 4 older executives and no younger executives at Senseonics. The oldest executive at Senseonics is Dr. Francine Ratner Kaufman M.D., Chief Medical Officer & Director, who is 72 years old. Learn More on Frederick T. Sullivan's age.

How do I contact Frederick T. Sullivan?

The corporate mailing address for Mr. Sullivan and other Senseonics executives is 20451 Seneca Meadows Parkway, Germantown, MD 20876-7005, United States. Senseonics can also be reached via phone at 301-515-7260 and via email at [email protected]. Learn More on Frederick T. Sullivan's contact information.

Has Frederick T. Sullivan been buying or selling shares of Senseonics?

Within the last three months, Frederick T. Sullivan has bought $31,840.20 in Senseonics stock. Most recently, on Friday, November 7th, Frederick T. Sullivan bought 5,415 shares of Senseonics stock. The stock was acquired at an average cost of $5.88 per share, with a total value of $31,840.20. Following the completion of the transaction, the chief financial officer now directly owns 157,028 shares of the company's stock, valued at $923,324.64. Learn More on Frederick T. Sullivan's trading history.

Who are Senseonics' active insiders?

Senseonics' insider roster includes Timothy Goodnow (CEO), Sharon Larkin (Director), Douglas Roeder (Director), and Frederick Sullivan (CFO). Learn More on Senseonics' active insiders.

Are insiders buying or selling shares of Senseonics?

During the last twelve months, Senseonics insiders bought shares 5 times. They purchased a total of 52,411 shares worth more than $329,909.80. The most recent insider tranaction occured on November, 10th when Director Edelman Steven bought 10,000 shares worth more than $65,500.00. Insiders at Senseonics own 3.6% of the company. Learn More about insider trades at Senseonics.

Information on this page was last updated on 11/10/2025.

Frederick T. Sullivan Insider Trading History at Senseonics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/7/2025Buy5,415$5.88$31,840.20157,028View SEC Filing Icon  
12/12/2024Buy6,246$7.60$47,469.60123,942View SEC Filing Icon  
See Full Table

Frederick T. Sullivan Buying and Selling Activity at Senseonics

This chart shows Frederick T Sullivan's buying and selling at Senseonics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Senseonics Company Overview

Senseonics logo
Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Read More

Today's Range

Now: $6.73
Low: $6.30
High: $6.89

50 Day Range

MA: $7.28
Low: $5.27
High: $11.30

2 Week Range

Now: $6.73
Low: $5.00
High: $28.00

Volume

366,949 shs

Average Volume

424,521 shs

Market Capitalization

$274.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92